Tele-Pharmacy Intervention to Improve Treatment Adherence

Completed · Not applicable

Conditions studied: Hyperlipidemia, Diabetes, Hypertension

In brief

The purpose of this cluster randomized controlled trial is to evaluate whether a novel tele-pharmacist-based intervention for patients with hyperlipidemia, hypertension, and diabetes improves medication adherence, disease control, and patients' understanding of their treatment.

Key facts

Study ID

NCT02512276

Run by

Brigham and Women's Hospital

People needed

4078

Starts

2015-08-01

Expected to finish

2017-10-01

Last updated by the study team

2019-06-06

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Filled and poorly adherent (defined as a PDC < 80%) to medication for hyperlipidemia, hypertension, or diabetes
• Suboptimal average adherence to all of the qualifying medications that a patient has filled (defined as combined (average of averages) PDC < 80%)
• For patients with hypertension or diabetes, poor or worsening disease control (according to relevant clinical targets)

You may not qualify if…

• Patients with <6 months of continuous enrolment in the health plan
• Patients with no available contact information

Where it is running

• Harvard Vanguard Medical Associates — Newton, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.